Research and experimental development on natural sciences and engineering
FARMAKON AS
Revenue 2025
NOK 1.8m
Operating profit
NOK 287,000
Equity
NOK 571,000
Incorporated
2022
Share capital
NOK 30,000
Roles
Daglig lederOle Christian Skare
Styrets lederOle Christian Skare
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| SKARE HOLDINGS AS | 100.0% | 30000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.